RxDoctor Payments Data

Brian Schirf, MD

Vascular & Interventional Radiology · South Bend, INNPI 1184840290

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.7%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 52.5% of the total. Reporting peaked in 2019 at $2,549 and has fallen 51.3% since, to $1,242 in 2025.

$9,884in general payments, 2019–2025

Across 145 payments — averaging $68.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Abbott$985
  • Shockwave Medical, Inc$579
  • Imperative Care, Inc$528
  • Philips North America LLC$387
  • Shape Memory Medical Inc.$253
  • plus $2K from 25 others
$3,500in ownership & investment interests, 2019–2025

Across 4 payments — averaging $875.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Shape Memory Medical Inc.$4K
  • Blackswan Vascular, Inc.$0

What the payments were for

  • Consulting fees$1,65717%
  • Speaking & faculty fees$2,70027%
  • Travel & lodging$1211%
  • Food & beverage$5,40755%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,884 in reported general payments places this provider in the 60th percentile of 74 vascular & interventional radiology providers in Indiana.

See all vascular & interventional radiology providers in Indiana

Medicare billing

Part B allowed, 2024
$94,971
Medicare patients
318
Services billed
961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate65$864

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →